DUSP1 and breast carcinoma: ,126 Higher expression of DUSP1 was also associated with reduced sensitivity of many other oncologic drugs, such as bortezomib, paclitaxel, mechlorethamine, tamoxifen, and doxorubicin in breast cancer.132